Pamisell has ranked among the top searched stocks on 9 days in the past month.


As of 12:31 PM on the 18th, Pamisell is trading at 19,500 KRW, up 1.04% from the previous day. This is a 14.1% decrease compared to August 26. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.


Today, foreigners have tentatively net purchased 31,918 shares. Over the past 5 days, individual investors have net sold 49,608 shares, while foreigners and institutions have net bought 44,429 shares and net sold 13,262 shares, respectively.




[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing